For this study, we hypothesised that FAK, Src and paxillin proteins contribute to the genesis and progression of RCC, and therefore they are immunohistochemically expressed in the tumour tissue and positively correlate with more advanced staging and other clinicopathological features. This evidence concerns the gene PTK2 and renal cell adenocarcinoma.